Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Macitentan or its derivativesPDL I DEC / 13
Magnesium glutamate hydrobromidePDL I DEC / 13
Magnesium sulfate for parenteral use II SEP / 98
Magnesium sulfate in injectable form for parenteral nutrition I JAN / 03
Manganese and its salts

In injectable form for parenteral nutrition.

I JAN / 03
Mannitol PDL

When sold and recommended for use as a diagnostic agent for the assessment of bronchial hyperresponsiveness.

I OCT / 19
Mannitol and its salts

Except when sold and recommended for use as a diagnostic agent for the assessment of bronchial hyperresponsiveness.

II OCT / 19
Maprotiline or its saltsPDL I DEC / 13
MaravirocPDL I DEC / 13
Marbofloxacin or its salts or derivativesPDL I DEC / 13
Maropitant or its saltsPDL I DEC / 13
Mazindol and its saltsTS I SEP / 98
Measles vaccine II DEC / 98
MebendazolePDL

For human use.

I DEC / 13
MebendazolePDL

For veterinary use - when sold to treat dogs only.

I DEC / 13
MebolazineC3 I JUN / 02
Mecamylamine or its saltsPDL I DEC / 13
Mechlorethamine or its saltsPDL I DEC / 13
Mecillinam or its salts or derivativesPDL

For veterinary use.

I DEC / 13
Meclizine and its salts.

when sold in concentrations of 25 mg or less per dosage unit

III MAY / 00
Meclizine or its saltsPDL

For human use - when sold in concentrations greater than 25 mg per dosage unit.

I DEC / 13
Meclofenamic acid or its saltsPDL I DEC / 13
Mecloqualone and any salt thereofC5 I JAN / 03
MedazepamTS I JUN / 02
Medetomidine or its saltsPDL I DEC / 13
Mefenamic acid or its saltsPDL I DEC / 13
MefenorexTS I JUN / 02
Mefloquine or its salts or derivativesPDL I DEC / 13
Megestrol or its saltsPDL I DEC / 13
Melanoma therapeutic vaccinePDL I DEC / 13
Melarsomine or its saltsPDL

For human use

I DEC / 13
Melarsomine or its saltsPDL

For veterinary use - when sold for the treatment of heartworm in dogs.

I DEC / 13
Meloxicam or its salts or derivativesPDL I DEC / 13
MelphalanPDL I DEC / 13
Memantine or its saltsPDL I DEC / 13
Meningococcus vaccine II MAR / 01
Menotropins (human)PDL I DEC / 13
Mepacrine or its saltsPDL I DEC / 13
Mepazine or its saltsPDL I DEC / 13
MephenoxalonePDL I DEC / 13
Mephentermine or its saltsPDL I DEC / 13
MephobarbitalC2 I JUN / 02
Mepivacaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Mepivacaine and its salts for ophthalmic or parenteral use II SEP / 98
MepolizumabPDL I AUG / 16
MeprobamateTS I SEP / 98
Mepyramine see pyrilamine U
MercaptopurinePDL I DEC / 13
MesaboloneC3 I JUN / 02
MesnaPDL I DEC / 13
Mesocarb and any salt thereofC4 I JAN / 03
Mesoridazine or its saltsPDL I DEC / 13
MesteroloneC3 I JUN / 02
MetaldehydePDL I DEC / 13
MetandienoneC3 I JUN / 02
Metaraminol bitartrate I SEP / 98
Metathoheptazine and its salts II SEP / 98
MetazocineN I JUN / 02
MetenoloneC3 I JUN / 02
Metformin or its salts or derivativesPDL I DEC / 13
MethabarbitalC2 I JUN / 02
Methacholine chloridePDL I DEC / 13
MethadoneN I JUN / 02
MethamphetamineC1 I JUN / 02
MethandriolC3 I JUN / 02
Methantheline and its salts II SEP / 98
MethaqualoneC1 I JUN / 02
Methazolamide or its saltsPDL I DEC / 13
Methdilazine and its salts II SEP / 98
Methenamine and its salts except for topical use II SEP / 98
Metheptazine and its salts II SEP / 98
Methicillin or its salts or derivativesPDL

For veterinary use.

I DEC / 13
MethimazolePDL I DEC / 13
MethisazonePDL I DEC / 13
Methocarbamol for parenteral use II SEP / 98
Methocarbamol. except for parenteral use III SEP / 98
Methoin (Mephenytoin) or its saltsPDL I DEC / 13
Methotrexate or its saltsPDL I DEC / 13
Methotrimeprazine or its saltsF1 I DEC / 13
Methoxamine or its saltsPDL I DEC / 13
MethoxsalenPDL I DEC / 13
Methoxy polyethylene glycol-epoetin betaPDL I DEC / 13
MethoxyfluranePDL I MAY / 18
Methyl salicylate in liquid dosage forms in concentrations greater than 30% II SEP / 98
MethyldesorphineN I JUN / 02
MethyldihydromorphineN I JUN / 02
Methyldopa or its saltsPDL I DEC / 13
Methylene Blue for parenteral use II SEP / 98
Methylnaltrexone or its saltsPDL

Including but not limited to methylnaltrexone bromide.

I JUN / 15
MethylparafynolPDL I DEC / 13
MethylphenidateC1 I JUN / 02
MethylphenobarbitalC2 I JUN / 02
MethylphenylisonipecotonitrileN I JUN / 02
MethyltestosteroneC3 I JUN / 02
MethyprylonTS I SEP / 98
Methysergide or its salts or derivativesPDL I DEC / 13
MetoclopramidePDL I DEC / 13
Metolazone or its saltsPDL I DEC / 13
Metomidate or its saltsPDL I DEC / 13
Metopimazine or its saltsPDL I DEC / 13
MetoponN I JUN / 02
Metoprolol or its saltsPDL I DEC / 13
MetriboloneC3 I JUN / 02
MetronidazolePDL I DEC / 13
Metyrapone or its saltsPDL I DEC / 13
Mexiletine or its saltsPDL I DEC / 13
Mezlocillin or its salts or derivativesPDL

For veterinary use

I DEC / 13
MiboleroneC3 I JUN / 02
Micafungin or its saltsPDL I DEC / 13
Miconazole and its salts. for vaginal use III SEP / 98
Miconazole and its salts.. for topical use U
Miconazole or its saltsPDL

For human use - except in preparations for topical or vaginal.

I DEC / 13
Miconazole or its saltsPDL

For veterinary use.

I DEC / 13
Midazolam and its saltsTS I SEP / 98
Midodrine or its saltsPDL I DEC / 13
Midostaurin or its saltsPDL I SEP / 17
Mifepristone or its derivativesPDL I AUG / 15
Migalastat or its saltsPDL I DEC / 17
MiglustatPDL I DEC / 13
Milbemycin or its derivativesPDL

For veterinary use - including but not limited to Moxidectin. Moxidectin when sold for the prevention of heartworm in dogs.

I DEC / 13
Milbemycin or its derivativesPDL

For human use - including but not limited to moxidectin. 

I DEC / 13
Milrinone or its saltsPDL I DEC / 13
Mineral tar except shampoos with concentrations less than 5% III SEP / 98
MinoxidilPDL

For veterinary use

I DEC / 13
MinoxidilPDL

except when sold in preparations for topical use in concentrations of 5% or less, for human use only

I AUG / 14
Minoxidil.

when sold in preparations for topical use in adults in concentrations of 5% or less, for human use only

U JUL / 17
Mirabegron or its saltsPDL I DEC / 13
Mirtazapine or its saltsPDL I DEC / 13
Mitomycin or its saltsPDL I DEC / 13
MitotanePDL I DEC / 13
Mitoxantrone or its saltsPDL I DEC / 13
MitratapidePDL I FEB / 14
Mivacurium chloridePDL I DEC / 13
Moclobemide or its salts or derivativesPDL I DEC / 13
Modafinil or its saltsPDL I DEC / 13
MolgramostimPDL I DEC / 13
Mometasone furoateNR

For the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 12 years of age and older.

I AUG / 15
Monobenzone II SEP / 98
Monoethanolamine oleate II SEP / 98
Montelukast or its saltsPDL I DEC / 13
MorpheridineN I JUN / 02
MorphineN I JUN / 02
Morphine-N-oxideN I JUN / 02
Moxifloxacin or its salts or derivativesPDL I DEC / 13
Mumps vaccine II DEC / 98
Mupirocin I SEP / 99
Muromonab-CD3PDL I DEC / 13
Mycophenolic acid or its salts or derivativesPDL

Including but not limited to Mycophenolate mofetil.

I DEC / 13
MyrophineN I JUN / 02

149 result(s)

Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled